We are live on ! Find out more
QUSVM

Qiming U.S. Ventures Management Portfolio holdings

AUM $55.6M
1-Year Est. Return 98.09%
This Fund
S&P 500
This Quarter Est. Return
+61.82%
1 Year Est. Return
+98.09%
3 Year Est. Return
+1,484.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$68.8M
AUM Growth
-$3.2M
Cap. Flow
-$3.63M
Cap. Flow %
-5.27%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
VTYX
Ventyx Biosciences
VTYX
+$3.63M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTYX
1
DELISTED
Ventyx Biosciences
VTYX
$26.1M 37.85%
746,370
-163,936
-18% -$3.63M
ICVX
2
DELISTED
Icosavax, Inc. Common Stock
ICVX
$11.1M 16.11%
3,510,228
– –
HLVX
3
DELISTED
HilleVax
HLVX
$9.55M 13.87%
558,923
– –
TRML
4
DELISTED
Tourmaline Bio
TRML
$7.71M 11.2%
293,261
– –
KZR
5
DELISTED
Kezar Life Sciences
KZR
$7.13M 10.36%
82,871
– –
JSPR icon
6
Jasper Therapeutics
JSPR
$22.9M
$4.62M 6.71%
585,298
– –
ELEV
7
DELISTED
Elevation Oncology
ELEV
$2.68M 3.89%
2,370,142
– –

Similar funds

CCCPV
Castle Creek Capital Partners VI San Diego, California $55.9M AUM 7.91% 1-Year Est. Return
ACM
Aurelius Capital Management New York $55.2M AUM 124.79% 1-Year Est. Return
SGA
Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return
NCFG
New Century Financial Group Princeton, New Jersey $56.3M AUM 16.99% 1-Year Est. Return
LAM
Lingohr Asset Management Duesseldorf, Germany $57.3M AUM 35.27% 1-Year Est. Return
ST
Skorpios Trust Limassol, Cyprus $53.2M AUM 90.96% 1-Year Est. Return
ITVII
IDG Technology Venture Investment IV Hong Kong $58.3M AUM 89.42% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Qiming U.S. Ventures Management's Q3 2022 Portfolio in Review

As of Q3 2022, Qiming U.S. Ventures Management held 7 positions worth $68.8M, down 4.4% from $72M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Qiming U.S. Ventures Management withdrew a net $3.63M in Q3 2022, reducing 1 holding. Its largest reduction was Ventyx Biosciences, cutting an estimated $3.63M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Qiming U.S. Ventures Management's biggest Q3 2022 reduction was Ventyx Biosciences, cutting an estimated $3.63M.
  • Qiming U.S. Ventures Management's ten largest holdings make up 100% of its $68.8M portfolio in Q3 2022.
  • Qiming U.S. Ventures Management opened 0 new positions and closed 0 in Q3 2022.
  • Qiming U.S. Ventures Management's portfolio value fell 4.4% quarter-over-quarter to $68.8M.

Based on Qiming U.S. Ventures Management's 13F filing for Q3 2022, filed 8 Nov 2022.